Status | Study |
Recruiting |
Study Name: Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma Condition: Papillary Thyroid Cancer Date: 2013-10-25 Interventions: Drug: percutaneous ethanol ablation The volume of 99% ethanol to be injected is calculated using a stand |
Completed |
Study Name: Leptin Levels in Papillary Thyroid Cancer Condition: Thyroid Cancer, Papillary Leptin Levels Date: 2012-08-03 |
Completed |
Study Name: Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 Condition: Papillary Thyroid Carcinoma Date: 2012-02-10 Interventions: Drug: GSK2118436 150mg twice per day orally for 28 days (42 days if Iodine-131 scan on Day 25 shows new |
Completed |
Study Name: Prophylactic Central Neck Dissection for Papillary Thyroid Cancer Condition: Papillary Thyroid Cancer Date: 2012-01-09 Interventions: Procedure: Total thyroidectomy |
Completed |
Study Name: BRAF V600E Mutations In Papillary Thyroid Carcinoma Condition: Papillary Thyroid Carcinoma Date: 2011-07-06 Interventions: Genetic: BRAF V600E POSITIVITY BRAF V600E mutation analysis will be made using the tumor tissues of the |
Completed |
Study Name: Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy Condition: Papillary Thyroid Carcinoma Date: 2011-05-13 |
Completed |
Study Name: A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy Condition: Papillary Thyroid Carcinoma Date: 2011-03-08 |
Completed |
Study Name: A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation Condition: Neoplasms Date: 2011-01-28 Interventions: Drug: Vemurafenib Vemurafenib 960 mg orally twice daily. |
Completed |
Study Name: Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma Condition: Thyroid Neoplasm Lymphatic Metastasis Date: 2010-04-12 Interventions: Procedure: prophylactic selective lateral neck dissection Level II, III, IV lymph node dissection |
Recruiting |
Study Name: Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia Condition: Thyroid Neoplasms Thyroid Cancer Date: 2010-03-16 Interventions: Procedure: Histological investigation of the SN 99m Tc- nanocolloid albumin, 10-15 MBq (volume 0.1-0.3 m |